Prediction of microbial infection and mortality in medical patients with fever:: Plasma procalcitonin, neutrophilic elastase-α1-antitrypsin, and lactoferrin compared with clinical variables

被引:80
作者
Bossink, AWJ
Groeneveld, ABJ
Thijs, LG
机构
[1] Free Univ Amsterdam, Acad Ziekenhuis, Med Intens Care Unit, Dept Internal Med, NL-1081 HV Amsterdam, Netherlands
[2] Vrije Univ Amsterdam, Cardiovasc Res Inst, Amsterdam, Netherlands
关键词
D O I
10.1086/520222
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Fever suggests the likelihood of severe microbial infection. Abnormal temperature, tachycardia, tachypnea, and abnormal white blood cell counts define the systemic inflammatory response syndrome (SIRS). In 300 hospitalized medical patients with fever, we determined clinical variables and procalcitonin, elastase-alpha(1)-antitrypsin, and lactoferrin levels in plasma. Of the patients, 718 had clinical infection (by clinical judgment) and 44% had microbial infection (by microbiological testing). SIRS occurred in 95%, and the 28-day mortality rate was 9%. The sensitivity for predicting microbial infection, bacteremia, and mortality was less but the specificity was greater for supranormal procalcitonin, elastase-alpha(1)-antitrypsin, and lactoferrin levels than for SIPS. The area under the receiver operating characteristic curve (AUC) for microbial infection was higher for procalcitonin and elastase-alpha(1)-antitrypsin levels than for clinical variables and lactoferrin level. The AUC for bacteremia was also higher for inflammatory factors (>0.70; P < .001) than for clinical variables. The AUC for mortality (P < .05) was 0.79 for the respiratory rate, 0.69 for elastase-alpha(1)-antitrypsin level, 0.65 for heart rate, 0.61 for procalcitonin level, and 0.60 for white blood cell count. In febrile medical patients, plasma procalcitonin and elastase-alpha(1)-antitrypsin levels may predict microbial infection and bacteremia better than (and mortality as well as) do clinical symptoms.
引用
收藏
页码:398 / 407
页数:10
相关论文
共 40 条
  • [1] Abraham E, 1998, LANCET, V351, P929
  • [2] FEVER OF NOSOCOMIAL ORIGIN - ETIOLOGY, RISK-FACTORS, AND OUTCOMES
    ARBO, MJ
    FINE, MJ
    HANUSA, BH
    SEFCIK, T
    KAPOOR, WN
    [J]. AMERICAN JOURNAL OF MEDICINE, 1993, 95 (05) : 505 - 512
  • [3] HIGH SERUM PROCALCITONIN CONCENTRATIONS IN PATIENTS WITH SEPSIS AND INFECTION
    ASSICOT, M
    GENDREL, D
    CARSIN, H
    RAYMOND, J
    GUILBAUD, J
    BOHUON, C
    [J]. LANCET, 1993, 341 (8844) : 515 - 518
  • [4] AN OVERVIEW OF MORTALITY RISK PREDICTION IN SEPSIS
    BARRIERE, SL
    LOWRY, SF
    [J]. CRITICAL CARE MEDICINE, 1995, 23 (02) : 376 - 393
  • [5] PREDICTING BACTEREMIA IN HOSPITALIZED-PATIENTS - A PROSPECTIVELY VALIDATED MODEL
    BATES, DW
    COOK, EF
    GOLDMAN, L
    LEE, TH
    [J]. ANNALS OF INTERNAL MEDICINE, 1990, 113 (07) : 495 - 500
  • [6] Predicting bacteremia in patients with sepsis syndrome
    Bates, DW
    Sands, K
    Miller, E
    Lanken, PN
    Hibberd, PL
    Graman, PS
    Schwartz, JS
    Kahn, K
    Snydman, DR
    Parsonnet, J
    Moore, R
    Black, E
    Johnson, BL
    Jha, A
    Platt, R
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1997, 176 (06) : 1538 - 1551
  • [7] TOWARD AN EPIDEMIOLOGY AND NATURAL-HISTORY OF SIRS (SYSTEMIC INFLAMMATORY RESPONSE SYNDROME)
    BONE, RC
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1992, 268 (24): : 3452 - 3455
  • [8] AMERICAN-COLLEGE OF CHEST PHYSICIANS SOCIETY OF CRITICAL CARE MEDICINE CONSENSUS CONFERENCE - DEFINITIONS FOR SEPSIS AND ORGAN FAILURE AND GUIDELINES FOR THE USE OF INNOVATIVE THERAPIES IN SEPSIS
    BONE, RC
    BALK, RA
    CERRA, FB
    DELLINGER, RP
    FEIN, AM
    KNAUS, WA
    SCHEIN, RMH
    SIBBALD, WJ
    ABRAMS, JH
    BERNARD, GR
    BIONDI, JW
    CALVIN, JE
    DEMLING, R
    FAHEY, PJ
    FISHER, CJ
    FRANKLIN, C
    GORELICK, KJ
    KELLEY, MA
    MAKI, DG
    MARSHALL, JC
    MERRILL, WW
    PRIBBLE, JP
    RACKOW, EC
    RODELL, TC
    SHEAGREN, JN
    SILVER, M
    SPRUNG, CL
    STRAUBE, RC
    TOBIN, MJ
    TRENHOLME, GM
    WAGNER, DP
    WEBB, CD
    WHERRY, JC
    WIEDEMANN, HP
    WORTEL, CH
    [J]. CRITICAL CARE MEDICINE, 1992, 20 (06) : 864 - 874
  • [9] Prediction of mortality in febrile medical patients - How useful are systemic inflammatory response syndrome and sepsis criteria?
    Bossink, AWJ
    Groeneveld, ABJ
    Hack, CE
    Thijs, LG
    [J]. CHEST, 1998, 113 (06) : 1533 - 1541
  • [10] PROCALCITONIN INCREASE AFTER ENDOTOXIN INJECTION IN NORMAL SUBJECTS
    DANDONA, P
    NIX, D
    WILSON, MF
    ALJADA, A
    LOVE, J
    ASSICOT, M
    BOHUON, C
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1994, 79 (06) : 1605 - 1608